Abstract: Various example embodiments for supporting application-based traffic control in a multipath network are presented herein. Various example embodiments for supporting application-based traffic control in a multipath network may be configured to support application-based traffic steering, application-based traffic blocking, or the like, as well as various combinations thereof. Various example embodiments for supporting application-based traffic control in a multipath network may be configured to support application-based traffic control in various types of multipath networks, such as multipath networks combining wireline and wireless access technologies between an end-user customer premises and a network gateway (e.g., between a hybrid-access customer premises equipment (HCPE) and a hybrid-access gateway (HAG), in a hybrid-access communication network (e.g.

Abstract: There is provided a multipole magnet for deflecting a beam of charged particles. The multipole magnet comprises a plurality of ferromagnetic poles and a plurality of permanent magnet assemblies to supply a magnetomotive force to the ferromagnetic poles. At least one of the permanent magnet assemblies has a plurality of discrete permanent magnet positions and a plurality of permanent magnets each fixed in one of the permanent magnet positions.

Abstract: Embodiments described herein may include apparatus, systems, techniques, or processes that are directed to access control mechanisms used to protect isolated memory regions. Embodiments described herein enable a distributed and efficient register structure enabling system providers to reduce cost and improve system performance while preventing malicious devices from accessing isolated memory regions. Isolated memory region access control registers are distributed through multiple access points or bridges but each may be optimized and minimized to allow fast and efficient access control. Other embodiments may be described and/or claimed.

Abstract: In an embodiment, an apparatus includes a memory access controller to be coupled to a memory and a memory management unit (MMU) coupled to the memory access controller. The MMU is to receive a memory transaction comprising an original transaction security attribute from a first device; responsive to the memory transaction comprising a first physical address of the memory, transmit the memory transaction to the memory access controller; and responsive to the memory transaction comprising a virtual address, generate a translated memory transaction comprising a translated physical address of the memory based on the virtual address and a translated transaction security attribute and transmit the translated memory transaction to the memory access controller, the translated physical address and the translated transaction security attribute associated with an operating system (OS) memory region of the memory associated with an OS. Other embodiments are described and claimed.

Abstract: A system comprising a network-on-chip (NOC) fabric comprising a plurality of routes to communicate data between a plurality of agents; a plurality of built-in self-test (BIST) generators, wherein a BIST generator of the plurality of BIST generators is coupled between an agent of the plurality of agents and the NOC fabric and is to transmit at least one test pattern through the NOC fabric; and a plurality of BIST checkers, wherein a BIST checker of the plurality of BIST checkers is coupled between the agent of the plurality of agents and the NOC fabric and is to receive at least one test pattern through the NOC fabric from at least one of the plurality of BIST generators and to verify whether the at least one test pattern was transmitted correctly through the NOC fabric.

Abstract: A sterile pharmaceutically acceptable aqueous solution, which solution is provided in a sealed container and comprises: a pharmaceutically acceptable aqueous solvent; viral particles or a physiologically active polypeptide; an excipient selected from a polyethyleneimine; a compound of formula (I) or a physiologically acceptable salt or ester thereof; or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and optionally, one or more sugars.

Abstract: The invention is directed to methods, reagents and kits for detecting incident HIV-1 infection.

Abstract: Example implementations as described herein are directed to systems and methods for processing a NoC specification for a plurality of performance requirements of a NoC, and generating a plurality of NoCs, each of the plurality of NoCs meeting a first subset of the plurality of performance requirements. For each of the plurality of NoCs, the example implementations involve presenting a difference between an actual performance of the each of the plurality of NoCs and each performance requirement of a second subset of the plurality of performance requirements and one or more costs for each of the plurality of NoCs.

Abstract: Example implementations as described herein are directed to systems and methods for processing a NoC specification for a plurality of performance requirements of a NoC, and generating a plurality of NoCs, each of the plurality of NoCs meeting a first subset of the plurality of performance requirements. For each of the plurality of NoCs, the example implementations involve presenting a difference between an actual performance of the each of the plurality of NoCs and each performance requirement of a second subset of the plurality of performance requirements and one or more costs for each of the plurality of NoCs.

Abstract: A method for preserving viral particles comprising: (a) providing an aqueous solution of (i) viral particles, (ii) optionally one or more sugars, and (iii) a compound of formula (I) or a physiologically acceptable salt or ester thereof and/or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (b) drying the solution to form a composition incorporating said viral particles.

Abstract: Example implementations as described herein are directed to systems and methods for processing a NoC specification for a plurality of performance requirements of a NoC, and generating a plurality of NoCs, each of the plurality of NoCs meeting a first subset of the plurality of performance requirements. For each of the plurality of NoCs, the example implementations involve presenting a difference between an actual performance of the each of the plurality of NoCs and each performance requirement of a second subset of the plurality of performance requirements and one or more costs for each of the plurality of NoCs.

Abstract: A method for preserving viral particles comprising: (a) providing an aqueous solution of (i) viral particles, (ii) optionally one or more sugars, and (iii) a compound of formula (I) or a physiologically acceptable salt or ester thereof and/or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and (b) drying the solution to form a composition incorporating said viral particles.

Abstract: Example implementations as described herein are directed to systems and methods for processing a NoC specification for a plurality of performance requirements of a NoC, and generating a plurality of NoCs, each of the plurality of NoCs meeting a first subset of the plurality of performance requirements. For each of the plurality of NoCs, the example implementations involve presenting a difference between an actual performance of the each of the plurality of NoCs and each performance requirement of a second subset of the plurality of performance requirements and one or more costs for each of the plurality of NoCs.

Abstract: Example implementations as described herein are directed to systems and methods for processing a NoC specification for a plurality of performance requirements of a NoC, and generating a plurality of NoCs, each of the plurality of NoCs meeting a first subset of the plurality of performance requirements. For each of the plurality of NoCs, the example implementations involve presenting a difference between an actual performance of the each of the plurality of NoCs and each performance requirement of a second subset of the plurality of performance requirements and one or more costs for each of the plurality of NoCs.

Abstract: Example implementations as described herein are directed to systems and methods for processing a NoC specification for a plurality of performance requirements of a NoC, and generating a plurality of NoCs, each of the plurality of NoCs meeting a first subset of the plurality of performance requirements. For each of the plurality of NoCs, the example implementations involve presenting a difference between an actual performance of the each of the plurality of NoCs and each performance requirement of a second subset of the plurality of performance requirements and one or more costs for each of the plurality of NoCs.

Abstract: Catalytic metal loss when using a hydroformylation catalyst comprising an organophosphite ligand is ameliorated by adding CO to a strip gas vaporizer.

Abstract: Data payload is passed over a boundary from a sender module (SM) on one side of the boundary to a receiver module (RM) on the other side of the boundary. The SM has two or more multiplexers to pass the data payload over to a receiver storage register in the RM. Each multiplexer has 1) its own read address pointer lane coming from sequencing logic located on the RM side and 2) data slots to send data payload from that multiplexer across the boundary to the receiver storage register in the RM in a qualified event synchronization. The sequencing logic ensures that the multiple read address pointers going to the multiplexers have a fixed alternating relationship amongst themselves; and thus, the multiple read address pointers syncopate between each other to move the data payload across the boundary to provide 100% throughput.

Abstract: Catalytic metal loss when using a hydroformylation catalyst comprising an organophosphite ligand is ameliorated by adding CO to a strip gas vaporizer.

Abstract: A sterile pharmaceutically acceptable aqueous solution, which solution is provided in a sealed container and comprises: a pharmaceutically acceptable aqueous solvent; viral particles or a physiologically active polypeptide; an excipient selected from a polyethyleneimine; a compound of formula (I) or a physiologically acceptable salt or ester thereof; or a compound of formula (II) or a physiologically acceptable salt or ester thereof; and optionally, one or more sugars.

Abstract: A method and apparatus for transmitting data over a clock-gated mesochronous clock domain boundary in an interconnect network of an integrated circuit. New data is received into storage buffers within a sender domain. The data is synchronized by sending time-controlled signals from storage elements in a sender control within the sender domain to corresponding inputs in a receiver control signal path in a receiver domain. Multiplexers are signaled to sequentially transmit the data from the storage buffers across the domain boundary to the receiver domain according to the time-controlled signals received from the sender control by the receiver control signal path, where the multiplexers receive signals from a data path pointer counter in communication with the receiver control signal path.